Bosentan 70771-1017
Product NDC
70771-1017- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA207760
Need to source Bosentan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bosentan | 62.5 mg/1 |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A Inducers [MoA]Endothelin Receptor Antagonist [EPC]
Packaging Options(5)
100 TABLET in 1 BOTTLE (70771-1017-1)
10 BLISTER PACK in 1 CARTON (70771-1017-4) / 10 TABLET in 1 BLISTER PACK (70771-1017-2)
500 TABLET in 1 BOTTLE (70771-1017-5)
60 TABLET in 1 BOTTLE (70771-1017-6)
180 TABLET in 1 BOTTLE (70771-1017-8)